← Open Payments lookup

ELIZABETH WEGNER-BUSCH: Open Payments

NPI 1679728380 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$418 in 23 payments from 10 companies in 2025. Trend: 2023 $450 · 2024 $471 · 2025 $418

Food & beverage: $418
CompanyPaymentsAmount
Novo Nordisk Inc4$79
ABBVIE INC.5$77
Bayer Healthcare Pharmaceuticals Inc.3$62
Lilly USA, LLC3$57
Amgen Inc.3$47
Merck Sharp & Dohme LLC1$24
Janssen Pharmaceuticals, Inc1$20
Vanda Pharmaceuticals Inc.1$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$16
Dexcom, Inc.1$16

Products named: Ozempic, Kerendia, VRAYLAR, MOUNJARO, QULIPTA, OTEZLA, CAPVAXIVE, SPRAVATO.

Industry payments across KS — which companies pay providers there.